Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-β1

In clinical trials recombinant-modified vaccinia virus Ankara expressing the Mycobacterium tuberculosis antigen 85A (MVA85A) induces approximately 10 times more effector T cells than any other recombinant MVA vaccine. We have found that in BCG primed subjects MVA85A vaccination reduces transforming...

Descripción completa

Detalles Bibliográficos
Autores principales: Fletcher, Helen A., Pathan, Ansar A., Berthoud, Tamara K., Dunachie, Susanna J., Whelan, Kathryn T., Alder, Nicola C., Sander, Clare R., Hill, Adrian V.S., McShane, Helen
Formato: Texto
Lenguaje:English
Publicado: Elsevier Science 2008
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631167/
https://www.ncbi.nlm.nih.gov/pubmed/18682270
http://dx.doi.org/10.1016/j.vaccine.2008.07.040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631167/
https://www.ncbi.nlm.nih.gov/pubmed/18682270
http://dx.doi.org/10.1016/j.vaccine.2008.07.040

Ejemplares similares